Atlas Trials

Kai Lin Xu，MD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kai Lin Xu，MD

RecordFirmDate
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) (NCT05907603)Kai Lin Xu，MD2023-03-08

Track Kai Lin Xu，MD automatically

Every clearance here is in the API, with alerts when new ones post.